Bipolar Test Free | Bipolar Disorder Test (MDQ Test)

What the MDQ Measures — and Why It Was Created

The Mood Disorder Questionnaire was developed specifically because standard depression screening tools were missing a critical pattern: the manic and hypomanic episodes that define bipolar disorder. When someone with bipolar disorder seeks help during a depressive episode — which is very common — a standard depression screen will identify depression but miss the elevated mood history entirely.

The MDQ addresses this by asking specifically about periods of time when the person felt unusually good, hyper, or energised — not just their current depressive symptoms. The three-part structure is deliberate: first it counts the number of manic/hypomanic symptom types (the 13 yes/no questions), then it asks whether these symptoms clustered together in the same time period (the clustering question), and finally asks how much impairment they caused. All three components are needed for a positive screen because many of the individual symptoms can occur in non-bipolar contexts.

A positive MDQ screen has been shown in research to have around 73% sensitivity for bipolar disorder — meaning it identifies approximately three in four people who genuinely have the condition. Its specificity is also strong, meaning it does not frequently flag people who do not have bipolar disorder. It is used worldwide as a standard first-step tool in psychiatric settings.

Bipolar 1 vs Bipolar 2: Understanding the Crucial Difference

The distinction between Bipolar 1 and Bipolar 2 is one of the most important — and most frequently misunderstood — aspects of bipolar disorder. Both involve episodes of elevated mood and depressed mood, but the nature and severity of the elevated mood episodes is entirely different.

Bipolar 1 Disorder requires at least one full manic episode in the person's lifetime. Full mania is severe — it involves significantly elevated or irritable mood for at least seven days, present most of the day, nearly every day, combined with three or more of: inflated self-esteem, dramatically decreased need for sleep, pressured speech, racing thoughts, distractibility, increased goal-directed activity, and dangerous impulsive behaviour. Full manic episodes cause serious impairment — they often result in hospitalisation, job loss, financial ruin, damaged relationships, or significant legal consequences. During severe mania, psychosis (hallucinations or delusions) can occur. Depressive episodes are also part of Bipolar 1, though their presence is not required for diagnosis.

Bipolar 2 Disorder involves hypomanic episodes rather than full mania. Hypomania looks like a milder version of mania — the same features are present, but the duration is shorter (at least four days rather than seven), the severity is lower, and the impairment is less severe. Crucially, hypomania does not cause the dramatic functional breakdown of full mania, and does not involve psychosis. In fact, many people experience hypomania as a pleasantly productive state — heightened energy, creativity, reduced need for sleep, and increased confidence. This is what makes Bipolar 2 so commonly missed: the "up" phases may not feel like a problem at all. Bipolar 2 requires at least one hypomanic episode AND at least one major depressive episode. People with Bipolar 2 often spend far more time depressed than hypomanic.

BPD vs Bipolar: A Genuinely Difficult Distinction

The question of whether someone has Bipolar disorder or Borderline Personality Disorder (BPD) — or both — is one of the most challenging differential diagnoses in psychiatry, and one that has enormous treatment implications. Confusing the two leads to the wrong treatment, which can cause real harm.

The most important distinguishing feature is the temporal structure of mood changes. In bipolar disorder, mood episodes last days to weeks with clear boundaries — the person transitions from a normal baseline into a manic/hypomanic episode, sustains it for a defined period, and then transitions back. In BPD, mood shifts are reactive and rapid — triggered by relationship events, perceived rejection, abandonment fears, or situational stressors, and lasting minutes to hours rather than days to weeks.

A second key difference is the trigger. Bipolar mood episodes tend to occur independently of external events — they arise from internal biological rhythms rather than being caused by what someone said or did. BPD mood shifts are almost always relational in origin — connected to how the person experiences their relationships and their sense of self in relation to others.

A third difference is the quality of the mood change. Manic episodes in bipolar disorder involve a qualitatively different mental state — dramatically increased energy, reduced need for sleep, racing thoughts, inflated self-esteem. The emotional intensity of BPD is powerful but does not typically include these features. That said, some people with BPD do experience what clinicians call "emotional dysregulation" that can look superficially similar to hypomania.

It is important to note that some people have both conditions simultaneously. The presence of one does not exclude the other. Only a thorough clinical assessment by an experienced clinician can make this distinction with confidence.

Why Bipolar Depression Is Particularly Dangerous to Miss

People with bipolar disorder spend, on average, significantly more time in depressive phases than in manic or hypomanic phases. This is especially true for Bipolar 2, where depression tends to be the dominant experience. The problem this creates is profound: someone experiencing bipolar depression who is assessed only during that depressive phase — without any exploration of their mood history — looks like they have unipolar major depression.

When bipolar depression is misdiagnosed as unipolar depression and treated with antidepressants alone, several serious problems can occur. First, antidepressants can trigger manic or hypomanic episodes in people with bipolar disorder. Second, they can cause rapid cycling — a state where mood episodes accelerate in frequency, becoming more numerous and harder to treat. Third, they can cause mixed states, where features of mania and depression occur simultaneously — a particularly distressing and dangerous combination associated with elevated suicide risk.

The red flags that should prompt a clinician to screen for bipolar disorder in someone presenting with depression include: a family history of bipolar disorder; early age of depression onset (adolescence or early 20s); multiple prior depressive episodes; depression with atypical features (sleeping and eating too much rather than too little); history of antidepressant-induced agitation, energy surge, or "too good" feeling; and a history of impulsive behaviour during past periods when mood was elevated.

If you are currently receiving treatment for depression and any of these features apply to you, raising the question of bipolar disorder with your prescriber is genuinely important — not an overreaction.

Bipolar Disorder in Teenagers and Young Adults

Bipolar disorder most commonly begins in late adolescence or early adulthood — the average age of onset is around 25, with many people experiencing their first episode in their teens. This timing creates real diagnostic challenges, because many of the features of bipolar disorder are also common aspects of normal adolescent development or adolescent mental health conditions.

Extreme mood swings are common in teenagers, making it hard to distinguish normal adolescent emotional intensity from genuinely pathological mood episodes. Sleep disruption is nearly universal in adolescents, so the reduced need for sleep characteristic of hypomania and mania is less distinctive. Risk-taking and impulsivity are developmentally typical in teenagers, making these features less diagnostic.

What distinguishes bipolar disorder in teenagers is the episodic nature of the mood changes — discrete periods that are qualitatively different from the teenager's normal baseline, involving changes in sleep, energy, speech, and thinking as well as mood. A teenager who is normally introverted and quiet becoming suddenly gregarious, sleeping very little, speaking rapidly, and engaging in unusual goal-directed activities — and then cycling into a period of profound depression — is presenting a pattern worth evaluating carefully.

Early diagnosis in adolescence is enormously important. Untreated bipolar disorder in teenagers is associated with significantly elevated rates of school dropout, substance use, relationship problems, and — most critically — suicide. The suicide risk in bipolar disorder is among the highest of any psychiatric condition, making accurate diagnosis and appropriate treatment potentially life-saving.

Bipolar Treatment: What Actually Works

Bipolar disorder is a chronic, recurrent condition that requires ongoing management — but with proper treatment, most people with bipolar disorder achieve meaningful stability and live productive, satisfying lives. The critical word is "proper": the treatment approaches that work for bipolar disorder are different from those used for unipolar depression, which is why accurate diagnosis matters so much.

Mood stabilisers are the cornerstone of bipolar treatment. Lithium remains the most extensively studied and effective mood stabiliser, with strong evidence for reducing both manic and depressive episodes and, importantly, reducing suicide risk. Valproate (Depakote) is particularly effective for mania. Lamotrigine (Lamictal) is especially valuable for bipolar depression and for Bipolar 2, with a more favourable side effect profile than lithium for many patients.

Atypical antipsychotics have become increasingly important in bipolar treatment — quetiapine (Seroquel), olanzapine (Zyprexa), lurasidone (Latuda), and aripiprazole (Abilify) all have evidence for specific phases of bipolar disorder.

Sleep regularity is one of the most powerful non-pharmacological interventions for bipolar disorder. Disrupted sleep is both a trigger for and a symptom of mood episodes. Maintaining a consistent sleep-wake schedule even on weekends — and treating sleep disorders promptly — meaningfully reduces episode frequency.

Psychotherapy approaches specifically adapted for bipolar disorder — including Interpersonal and Social Rhythm Therapy (IPSRT), CBT adapted for bipolar, and psychoeducation — significantly improve outcomes when added to medication.

Pharmacogenetic testing — a relatively new tool that analyses genetic variants affecting how a person metabolises psychiatric medications — can help identify which medications are most likely to be effective and well-tolerated for a specific individual, reducing the trial-and-error process that many people with bipolar disorder experience.